Integrated Safety Analysis on Skin Cancers among Patients with Psoriasis Receiving Ixekizumab in Clinical Trials

INTRODUCTION: Limited data exist on skin cancer risk in patients with psoriasis using biologics. Here, we report treatment-emergent adverse events (TEAEs) of skin cancer in patients treated with ixekizumab from psoriasis clinical trials. METHODS: Integrated safety databases from 17 clinical trials o...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Saxon D., Stratigos, Alexandros, Augustin, Matthias, Carrascosa, Jose Manuel, Grond, Susanne, Riedl, Elisabeth, Xu, Wen, Patel, Himanshu, Lebwohl, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366039/
https://www.ncbi.nlm.nih.gov/pubmed/37351831
http://dx.doi.org/10.1007/s13555-023-00966-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366039/
https://www.ncbi.nlm.nih.gov/pubmed/37351831
http://dx.doi.org/10.1007/s13555-023-00966-4

Ejemplares similares